REVANCE THE
NASDAQ: RVNC (Revance Therapeutics, Inc.)
Last update: 11 hours ago3.65
-0.02 (-0.54%)
| Previous Close | 3.67 |
| Open | 3.65 |
| Volume | 3,180,269 |
| Avg. Volume (3M) | 3,114,090 |
| Market Cap | 381,023,520 |
| Price / Sales | 1.37 |
| 52 Weeks Range | |
| Earnings Date | 26 Feb 2025 - 3 Mar 2025 |
| Profit Margin | -71.78% |
| Operating Margin (TTM) | -53.87% |
| Diluted EPS (TTM) | -3.34 |
| Quarterly Revenue Growth (YOY) | 10.70% |
| Current Ratio (MRQ) | 4.12 |
| Operating Cash Flow (TTM) | -190.89 M |
| Levered Free Cash Flow (TTM) | -167.85 M |
| Return on Assets (TTM) | -24.36% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bullish |
| Biotechnology (Global) | Mixed | Bullish | |
| Stock | Revance Therapeutics, Inc. | Mixed | Mixed |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 0.0 |
| Average | -0.21 |
|
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Growth |
| % Held by Insiders | 8.56% |
| % Held by Institutions | 87.64% |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |